Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...
Aura Biosciences has been able to advance its pipeline with great clinical success recently. Click here to read an analysis ...
Lecap Asset Management Ltd. bought a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...
A shorter regimen of three cycles of adjuvant chemotherapy was noninferior to a standard six-cycle regimen among patients ...
If your healthcare provider suspects wet AMD, they will work to differentiate that condition from polypoidal choroidal ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...
West Virginia Health Right will host its inaugural We Care Day, a one-day clinic offering free medical, dental and vision ...
Medcare Hospital Al Safa, Dubai, has introduced Airdoc, an AI-powered retinal imaging machine that can assess the risk of 35 ...
Koss Olinger Consulting LLC increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7 ...
Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic ...